Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.70)
# 156
Out of 5,148 analysts
19
Total ratings
73.68%
Success rate
43.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Buy | $90 → $114 | $62.90 | +81.24% | 3 | Mar 2, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $37 | $22.81 | +62.21% | 2 | Feb 3, 2026 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $36.69 | +36.28% | 1 | Dec 15, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $60 | $16.15 | +271.52% | 2 | Dec 8, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $50 → $60 | $45.61 | +31.55% | 4 | Dec 3, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $6.53 | +206.28% | 3 | Nov 13, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $6.29 | +281.56% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.76 | +2,527.78% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $5.52 | +153.62% | 1 | Aug 15, 2025 |
Structure Therapeutics
Mar 2, 2026
Maintains: Buy
Price Target: $90 → $114
Current: $62.90
Upside: +81.24%
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Buy
Price Target: $37
Current: $22.81
Upside: +62.21%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $36.69
Upside: +36.28%
Dyne Therapeutics
Dec 8, 2025
Maintains: Buy
Price Target: $46 → $60
Current: $16.15
Upside: +271.52%
Maze Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $50 → $60
Current: $45.61
Upside: +31.55%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $6.53
Upside: +206.28%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $6.29
Upside: +281.56%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.76
Upside: +2,527.78%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $5.52
Upside: +153.62%